Skip to main content
SpringerLink
Log in

Brain Impact of Sex Steroid Withdrawal at Menopause

  • Chapter
  • First Online:
Pre-Menopause, Menopause and Beyond

Part of the book series: ISGE Series ((ISGE))

  • 1287 Accesses

Abstract

In the last century, longer female life expectancy has implied that women now live a third of their lives beyond the end of their ovarian function, increasing the need for new therapeutic strategies to facilitate successful aging (defined as low probability of disease), high cognitive and physical abilities, and active engagement in life. The incidence of hypertension, diabetes mellitus, and psychiatric and degenerative brain diseases, especially stroke and dementia, is more frequently seen in older people. Each of these conditions can, separately or in combination, results in similar signs and symptoms of cognition, memory, mood, and motor function disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Bromberger JT, Meyer PM, Kravitz HM et al (2001) Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 91:1435–1442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. North American Menopause Society (2006) Menopause guidebook, 6th edn. North American Menopause Society, Cleveland, OH

    Google Scholar 

  3. Gallicchio L, Schilling C, Miller SR, Zacur H, Flaws JF (2007) Correlates of depressive symptoms among women undergoing the menopausal transition. J Psychosom Res 63:263–268

    Article  PubMed  Google Scholar 

  4. Moline ML, Broch L, Zak RZ (2004) Sleep in women across the life cycle from adulthood through menopause. Med Clin N Am 88:705–736

    Article  PubMed  Google Scholar 

  5. McKinley JB, McKinley SM, Brambilla D (1987) The relative contributions of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav 28:345–363

    Article  Google Scholar 

  6. Avis NE, Stellato R, Crawford S et al (2001) Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52:345–356

    Article  CAS  PubMed  Google Scholar 

  7. Bromberger JT, Assmann SF, Avis NE, Schocken M, Kravitz HM, Cordal A (2003) Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 15:347–356

    Article  Google Scholar 

  8. Schmidt PJ, Haq N, Rubinow DR (2004) A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 161:2238–2244

    Article  PubMed  Google Scholar 

  9. Murray CJL, Lopez AD (eds) (1996) The global burden of disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Harvard School of Public Health, Cambridge, MA

    Google Scholar 

  10. Richards M, Rubinow D, Daly R, Schmidt P (2006) Premenstrual symptoms and perimenopausal depression. Am J Psychiatry 163(1):133–137

    Article  PubMed  Google Scholar 

  11. Bromberger JT, Matthews KA (1996) A longitudinal study of the effects of pessimism, trait anxiety, and life stress on depressive symptoms in middle-aged women. Psychol Aging 11(2):207–213

    Article  CAS  PubMed  Google Scholar 

  12. Avis NE, Brambilla D, McKinlay SM, Vass K (1994) A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women’s Health Study. Ann Epidemiol 4(3):214–220

    Article  CAS  PubMed  Google Scholar 

  13. Freeman EW, Sammel MD, Grisso JA et al (2001) Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 10(1):67–76

    Article  CAS  PubMed  Google Scholar 

  14. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL (2006) Risk for new onset depression during the menopausal transition. Arch Gen Psychiatry 63:385–390

    Article  PubMed  Google Scholar 

  15. Freeman EW, Sammel MD, Lin H, Gracia CR, Pien GW, Nelson DB, Sheng L (2007) Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 110(2 Pt 1):230–240

    Article  PubMed  Google Scholar 

  16. Rocca WA, Shuster LT, Grossardt BR et al (2009) Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Women’s Health (Lond Engl) 5(1):39–48

    Article  Google Scholar 

  17. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF (2007) Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas 56(1):54–60

    Article  CAS  PubMed  Google Scholar 

  18. Bernardi F, Pieri M, Stomati M et al (2003) Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women. Gynecol Endocrinol 17(1):65–77

    Article  CAS  PubMed  Google Scholar 

  19. Rivera CM, Grossardt BR, Rhodes DJ, Rocca WA (2009) Increased mortality for neurological and mental diseases following early bilateral oophorectomy. Neuroepidemiology 33(1):32–40

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gold EB, Sternfeld B, Kelsey JL et al (2000) Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 152(5):463–473

    Article  CAS  PubMed  Google Scholar 

  21. Woods NF, Mitchell ES, Adams C (2000) Memory functioning among midlife women: observations from the Seattle Midlife Women’s Health Study. Menopause 7(4):257–265

    Article  CAS  PubMed  Google Scholar 

  22. Maki PM, Drogos LL, Rubin LH, Banuvar S, Shulman LP, Geller SE (2008) Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 15(5):848–856

    Article  PubMed  PubMed Central  Google Scholar 

  23. LeBlanc ES, Janowsky J, Chan BK, Nelson HD (2001) Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 285(11):1489–1499

    Article  CAS  PubMed  Google Scholar 

  24. Tang MX, Jacobs D, Stern Y et al (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348:429–432

    Article  CAS  PubMed  Google Scholar 

  25. Kawas C, Resnick S, Morrison A et al (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging [published correction appears in Neurology. 51:654]. Neurology 48:1517–1152

    Article  CAS  PubMed  Google Scholar 

  26. Baldereschi M, Di Carlo A, Lepore V et al (1998) Estrogen-replacement therapy and Alzheimer’s disease in the Italian Longitudinal Study on Aging. Neurology 50(4):996–1002

    Article  CAS  PubMed  Google Scholar 

  27. Zandi PP, Carlson MC, Plassman BL et al (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288(17):2123–2129

    Article  CAS  PubMed  Google Scholar 

  28. Resnick SM et al (2006) Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab 91(5):1802–1810

    Article  CAS  PubMed  Google Scholar 

  29. Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBlanc ES et al (2013) Long- term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med 173(15):1429

    Article  PubMed  Google Scholar 

  30. Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S (2015) Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, con- trolled KEEPS-cognitive and affective study. PLoS Med 12(6):e1001833

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obstetrics and Gynecology, University Hospital of Geneva, Geneva, Switzerland

    Nicola Pluchino

  2. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

Authors
  1. Nicola Pluchino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea R. Genazzani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea R. Genazzani .

Editor information

Editors and Affiliations

  1. Professor emeritus for Gynaecological Endocrinology and Reproductive Medicine, University of Bern, Bern, Switzerland

    Martin Birkhaeuser

  2. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

Rights and permissions

Reprints and permissions

Copyright information

© 2018 International Society of Gynecological Endocrinology

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pluchino, N., Genazzani, A.R. (2018). Brain Impact of Sex Steroid Withdrawal at Menopause. In: Birkhaeuser, M., Genazzani, A. (eds) Pre-Menopause, Menopause and Beyond. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-63540-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63540-8_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63539-2

  • Online ISBN: 978-3-319-63540-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation